You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Small Cell Lung Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Carboplatin, Etoposide)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • BI 764532
  • +5 more
  • (no location specified)
Oct 17, 2023

Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • Neuroendocrine Neoplasms
  • BI 764532
  • [89Zr]Zr-BI 764532
  • (no location specified)
Jul 31, 2023

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)

Not yet recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • ZG006
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Aug 6, 2023

Molecular Analysis and Treatment Options of SCLC

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Shanghai, China
    Shanghai Chest Hospital
Jul 6, 2023

Colorectal Tumors, NSCLC, Stomach Tumors Trial (SGN-CEACAM5C)

Not yet recruiting
  • Colorectal Neoplasms
  • +5 more
  • (no location specified)
Nov 9, 2023

Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Topotecan)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • (no location specified)
Aug 7, 2023

Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Self-administered survey at hospital
  • +2 more
  • (no location specified)
Oct 3, 2023

Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
  • (no location specified)
Sep 19, 2023

Small Cell Lung Cancer Trial in Cleveland (Alisertib)

Not yet recruiting
  • Small Cell Lung Cancer
  • Cleveland, Ohio
    Cleveland Clinic
Oct 18, 2023

Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

Not yet recruiting
  • Limited Stage Lung Small Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Nov 10, 2023

Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, Ezabenlimab)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • Neuroendocrine Neoplasms
  • (no location specified)
May 25, 2023

Small Cell Lung Cancer Trial (Tarlatamab)

Available
  • Small Cell Lung Cancer
  • (no location specified)
Sep 26, 2023

Stage IB Non-small Cell Lung Cancer

Completed
  • Stage IB Non-Small Cell Lung Carcinoma
    • Shanghai, China
      180 Fenglin Road
    Jul 29, 2023

    Extensive Stage Small Cell Lung Cancer

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
      • Changsha, Hunan, China
        Hunan Cancer hospital
      Aug 6, 2023

      Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

      Not yet recruiting
      • Relapsed Small Cell Lung Cancer
      • Irinotecan hydrochloride liposome Injection
      • Topotecan
      • Beijing, China
        Cancer Hospital, Chinese Academy of Medical Sciences
      Nov 7, 2023

      Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

      Not yet recruiting
      • Extensive Stage Small Cell Lung Cancer
      • hSTC810 400 mg + Paclitaxel
      • hSTC810 800 mg + Paclitaxel
      • (no location specified)
      Aug 24, 2023

      Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)

      Not yet recruiting
      • Small Cell Lung Carcinoma
      • Neuroendocrine Neoplasms
      • BI 764532
      • (no location specified)
      May 22, 2023

      QOL After SURGERY and ADJUVANT Treatment

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Quality of Life
      • Questionnaires
      • Salamanca, Spain
        Hospital Clínico Universitario
      Oct 30, 2023

      Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

      Active, not recruiting
      • Non Small Cell Lung Cancer
      • Immune signature in serum associated to the metabolic signature
      • Meta-genomic signature of intestinal flora
      • La Tronche, Isère, France
        University Hospital, Grenoble
      Jan 6, 2023

      Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Duarte, New Haven (procedure, drug, radiation, other)

      Not yet recruiting
      • Lung Non-Small Cell Carcinoma
      • Stage IV Lung Cancer AJCC v8
      • Biospecimen Collection
      • +5 more
      • Duarte, California
      • +1 more
      Aug 24, 2023

      Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

      Not yet recruiting
      • Locally Advanced Alveolar Soft Part Sarcoma
      • +9 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Oct 10, 2023

      NSCLC, Oligoprogressive, Small-cell Lung Cancer Trial in Sacramento (Ablative local therapy)

      Recruiting
      • Non-small Cell Lung Cancer
      • +2 more
      • Ablative local therapy
      • Sacramento, California
        University of California, Davis
      Oct 27, 2023

      Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

      Recruiting
      • Small Cell Lung Cancer
      • Biospecimen Collection
      • Indianapolis, Indiana
      • +1 more
      Jun 2, 2023

      Molecular Subtyping of Extensive Stage Small Cell Lung Cancer

      Recruiting
      • SCLC,Extensive Stage
      • PD-(L)1 antibody immunotherapy
      • Beijing, Beijing, China
        Peking University Cancer Hospital & Institute
      Jul 3, 2023

      Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)

      Recruiting
      • Extensive Small Cell Lung Cancer
      • Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
      • Jinan, Shan Dong, China
        The First Affiliated Hospital of Shandong First Medical Universi
      Nov 6, 2023